Icon

ZUPLENZ (nda022524)- (4MG,8MG)

ONDANSETRON AQUESTIVE
4MG,8MG
No Yes
2030-Jul-13 Expired
None None
None No
ZUPLENZ is a 5-HT3 receptor antagonist indicated for the prevention of: • nausea and vomiting associated with highly emetogenic cancer chemotherapy, including cisplatin greater than or equal to 50 mg/m2, in adults. • nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy in adults and pediatric patients 4 years of age and older. • nausea and vomiting associated with radiotherapy in adult patients receiving either total body irradiation, single high-dose fraction to abdomen, or daily fractions to the abdomen. • postoperative nausea and/or vomiting in adults.
0 0 0
Total Other Developers 3
Drugs with Suitability No
4MG ** ** - - -
8MG ** ** - - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.